Identification of PDE5A:E90K: A Polymorphism in the Canine Phosphodiesterase 5A Gene Affecting Basal cGMP Concentrations of Healthy Dogs

Identification of PDE5A:E90K: A Polymorphism in the Canine Phosphodiesterase 5A Gene Affecting Basal cGMP Concentrations of Healthy Dogs

Bibliographic Details
Main Authors:	Stern, J. A., Reina‐Doreste, Y., Chdid, L., Meurs, K. M.
Format:	Online
Language:	English
Published:	John Wiley and Sons Inc. 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895552/

Similar Items

Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling
by: Mullershausen, Florian, et al.
Published: (2003)

PDE3 is the major cGMP-PDE in adult mouse ventricular cardiomyocytes
by: Götz, Konrad R, et al.
Published: (2013)

cGMP Signaling, Phosphodiesterases and Major Depressive Disorder
by: Reierson, Gillian W, et al.
Published: (2011)

Asymmetric properties of rod cGMP Phosphodiesterase 6 (PDE6): structural and functional analysis
by: Qureshi, Bilal M, et al.
Published: (2015)

Transient kinetics of a cGMP-dependent cGMP-specific phosphodiesterase from Dictyostelium discoideum
Published: (1984)

PDE2, a component of the NO/cGMP signalling in the hippocampus
by: Schönle, Isabel, et al.
Published: (2011)

cGMP kinase I, cardiac hypertrophy and PDE inhibition
by: Patrucco, Enrico, et al.
Published: (2011)

cGMP-Prkg1 signaling PDE5 inhibition shelter cochlear hair cells and hearing function
by: Knipper, Marlies, et al.
Published: (2013)

Role of Ser102 and Ser104 as Regulators of cGMP Hydrolysis by PDE5A
by: Carøe Nordgaard, Julie, et al.
Published: (2014)

Acute effects of phosphodiesterase 5 (PDE5) inhibition, ANP and NO on epididymal contractility are preserved despite chronic PDE5 exposure
by: Mietens, Andrea, et al.
Published: (2011)

In situ cGMP phosphodiesterase and photoreceptor potential in gecko retina
Published: (1986)

The cGMP-phosphodiesterase and its contribution to sensitivity regulation in retinal rods
Published: (1995)

Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension
by: Mergia, Evanthia, et al.
Published: (2016)

Identification of cytosolic phosphodiesterases in the erythrocyte: A possible role for PDE5
by: Adderley, Shaquria P., et al.
Published: (2011)

Calcium/Calpain mediated regulation of cyclic nucleotide phosphodiesterases, PDE3A and PDE5, in human platelets
by: Rybalkina, Irina G, et al.
Published: (2011)

Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A
by: Alexander, M S, et al.
Published: (2016)

NO/cGMP signalling in platelets
by: Schinner, Elisabeth, et al.
Published: (2009)

cGMP and cardiac hypertrophy
by: Perera, Ruwan K, et al.
Published: (2015)

The NO/cGMP pathway inhibits transient cAMP signals through the activation of PDE2 in striatal neurons
by: Polito, Marina, et al.
Published: (2013)

Modulation of cGMP/cAMP crosstalk on the level of PDE3 in animals lacking NO-sensitive guanylyl cyclase
by: Friebe, Andreas, et al.
Published: (2015)

Rapid nitric oxide–induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme
by: Mullershausen, Florian, et al.
Published: (2001)

Phosphodiesterase (PDE)-4 Inhibitors and COPD Correlation with Cancer
by: Organtzis, John, et al.
Published: (2014)

Optimization of extraction methods for determination of phosphodiesterase-5 (PDE5) inhibitors in premix coffee
by: Zailina, A.M, et al.
Published: (2013)

Optimization of extraction methods for determination of phosphodiesterase-5 (PDE5) inhibitors in premix coffee
by: Tuan Norhafizah binti Tuan Zakaria
Published: (2013)

Development of a New Radiofluorinated Quinoline Analog for PET Imaging of Phosphodiesterase 5 (PDE5) in Brain
by: Liu, Jianrong, et al.
Published: (2016)

cGMP steers axons home
by: LeBrasseur, Nicole
Published: (2002)

A novel pathway of cGMP
by: Kuhn, Michaela, et al.
Published: (2011)

The role of cGMP and PKG in cardioprotection
by: Downey, James M, et al.
Published: (2009)

NO-cGMP signalling and cancer therapy
by: Bian, Ka, et al.
Published: (2013)

Role of cGMP in fat and metabolism
by: Pfeifer, Alexander, et al.
Published: (2013)

cGMP-Phosphodiesterase Inhibition Enhances Photic Responses and Synchronization of the Biological Circadian Clock in Rodents
by: Plano, Santiago A., et al.
Published: (2012)

cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants
by: Olivares-González, Lorena, et al.
Published: (2016)

Phosphodiesterase 9A Controls Nitric-oxide Independent cGMP and Hypertrophic Heart Disease
by: Lee, Dong I., et al.
Published: (2015)

Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia
by: Monfort, Pilar, et al.
Published: (2005)

Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
by: Wen, Lai, et al.
Published: (2013)

cGMP becomes a drug target
by: Schlossmann, Jens, et al.
Published: (2012)

Role of cGMP/PKG in fat tissue
by: Pfeifer, Alexander
Published: (2011)

cGMP and PKGI are required for vascular BMP signaling
by: Schwappacher, Raphaela, et al.
Published: (2011)

Role of NO/cGMP signalling in VEGF-mediated angiogenesis
by: Jäger, Ronald, et al.
Published: (2011)

Vascular and renal function of cGMP signalling
by: Schlossmann, Jens, et al.
Published: (2011)